Lymphosarcoma with plasmacytoid differentiation in a scarlet macaw (Ara macao)
Related Experiment Video
Updated: Nov 1, 2026

Laparoscopic Technique for Serial Collection of Liver and Mesenteric Lymph Nodes in Macaques
Published on: May 2, 2017
J A Ramos-Vara1, E J Smith, G L Watson
1Animal Health Diagnostic Laboratory, Michigan State University, East Lansing 48824, USA.
Abstract:
A lymphosarcoma in a scarlet macaw (Ara macao) affecting periocular structures is described. Microscopically and ultrastructurally, many of the lymphoid cells had plasmacytoid features. Polymerase chain reaction amplification failed to detect exogenous avian retrovirus RAV-1 in the neoplastic mass.
Insights
A rare lymphosarcoma in a scarlet macaw (Ara macao) was identified, affecting the eye area. Microscopic analysis revealed lymphoid cells with plasmacytoid features, and no avian retrovirus RAV-1 was detected.
Area of Science:
- Avian pathology
- Veterinary oncology
- Comparative pathology
Background:
- Lymphosarcoma is a significant neoplastic condition in avian species.
- Periocular tumors can impact a bird's vision and overall health.
- Scarlet macaws (Ara macao) are susceptible to various health issues.
Observation:
- A case of lymphosarcoma in a scarlet macaw is presented.
- The tumor affected the periocular region, surrounding the eye.
- Microscopic examination revealed neoplastic lymphoid cells with plasmacytoid characteristics.
Findings:
- Ultrastructural analysis confirmed plasmacytoid features in the lymphoid cells.
- Polymerase chain reaction (PCR) testing did not detect avian retrovirus RAV-1 in the tumor.
- The absence of RAV-1 suggests alternative etiologies for this lymphosarcoma.
Implications:
- This case contributes to the understanding of avian lymphosarcoma, particularly in psittacine birds.
- The findings highlight the importance of detailed histopathological and ultrastructural evaluation for accurate diagnosis.
- Further research is needed to elucidate the specific causes of lymphosarcoma in macaws lacking common retroviral markers.